drugset
Drugs / Multi-antigen CMV-Modified Vaccinia Ankara Vaccine
last change Dec 2021 re-read 3 minutes ago

Multi-antigen CMV-Modified Vaccinia Ankara Vaccine

Vaccine

Investigated by
City of Hope Medical Center

Trials 1

today NCT03438344 · Ph 2
20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03438344 Dec 2018 → Dec 2021 Hodgkins lymphoma, acute myeloid leukemia, chronic lymphocytic leukemia/small lymphocytic lymphoma, disease related to hematopoietic stem cell transplant +3 City of Hope Medical Center Withdrawn No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Multi-antigen CMV-Modified Vaccinia Ankara Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT03438344 ↗
Modality Vaccine “multi-antigen CMV-modified vaccinia Ankara vaccine” NCT03438344 ↗
Route Intramuscular “Patients receive multi-antigen CMV-modified vaccinia Ankara vaccine intramuscularly (IM) on days 28 and 56 post-HCT.” NCT03438344 ↗